best price photoshop cs4 buy autocad 2005 cheap quicken premier 2010 buy microsoft outlook 2007 upgrade best price adobe cs5 master collection cost of autodesk autocad structural detailing 2015 purchase adobe lightroom price of adobe acrobat 9 standard cheap 2007 office professional buying photoshop cs2 best price photoshop elements 6.0 purchase ms project 2007 upgrade buy autodesk building design suite premium 2015 commercial cost of matlab software best buy word 2007
buy aperture 3 buy autocad electrical 2010 buy rosetta stone english buy quicken home business uk adobe photoshop elements buy used rosetta stone french buy symantec norton ghost 12.0 cost of microsoft office for mac best buy office home and student 2010 purchase encarta kids buy paperport 10 buy adobe acrobat for mac cheapest autocad 2012 office 2013 teacher discount buy windows xp professional key

The Oral Cancer Foundation Helps Sponsor HPV/Oral Cancer Study

Tue, Nov 1, 2011

OCF In The News, Oral Cancer News

Source: Jada.org

An increase in the incidence and survival of oropharyngeal cancer in the United States since 1984 can be attributed to the human papilloma-virus (HPV) infection, say researchers in an article published online Oct. 3 in Journal of Clinical Oncology.

The results of previous studies have shown that oropharyngeal cancers can be divided into two separate diseases with distinct causes: HPV-negative cancers, which are associated with tobacco and alcohol use; and HPV-positive cancers, which are linked to certain types of HPV, a sexually transmitted virus.

Patients with HPV-positive oropharyngeal cancer tend to be younger than and to have better survival rates than patients with HPV-negative cancer.

To determine HPV infection’s role, researchers led by Anil K. Chaturvedi, PhD, National Cancer Institute, National Institutes of Health, Bethesda, Md., tested for HPV infection 271 archived samples of cancerous oropharyngeal tissue collected between 1984 and 2004 at three population-based cancer registries located in Hawaii, Iowa and Los Angeles in the National Cancer Institute’s Surveillance, Epidemiology and End Results Residual Tissue Repositories Program. By using a variety of molecular assays, researchers found that the proportion of oropharyngeal cancers that were HPV-positive—particularly among men—increased over time, from 16.3 percent for cancers diagnosed from 1984 to 1989 to 72.7 percent for cancers diagnosed from 2000 to 2004. They also found that the incidence of HPV-negative oropharyngeal cancers declined by 50 percent between 1988 and 2004, likely due to declines in smoking and tobacco use.

According to senior author Maura Gillison, MD, PhD, a professor of medicine at The Ohio State University Comprehensive Cancer Center in Columbus, the study’s results suggest that if these trends continue, HPV-positive oropharyngeal cancer will become the major form of head and neck cancer and the leading HPV-associated cancer in the United States by 2020, surpassing cervical cancer.

“These increases may reflect increases in sexual behavior, including increases in oral sex,” said Dr. Gillison. She noted that approximately 90 to 95 percent of HPV-positive oropharyngeal cancers were caused by one HPV type—HPV16, which is targeted by vaccines for cervical cancer.

“With HPV vaccines, we have a great opportunity to potentially prevent oropharynx cancers in future generations, including in boys and men, but studies need to be done to evaluate the efficacy of HPV vaccines in preventing oral HPV infections,” Dr. Gillison said.

This study was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health; The James Comprehensive Cancer Center; The Ohio State University; and the Oral Cancer Foundation.

Print Friendly
Be Sociable, Share!
, , , , , , , , , , , , ,

Leave a Reply

You must be logged in to post a comment.